Ideas That Generate Results
US Clinical Laboratory Testing Market Assessment
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jul, 2012| No. of Pages : 45
The US represents an attractive destination for healthcare services’ market segments, especially clinical lab testing, which has evolved as a major source of decisive factor for healthcare professionals and that too despite garnering a low proportion of total medical spending. It is estimated that the market for clinical lab testing in the US reached to the mark of US$ 61 Billion in 2011 backed by factors, such as aging population, active private sector participation and rising awareness level. With the emergence of new technologies, the market is likely to register further to an optimum CAGR in future.
Currently, the market is dominated by routine testing followed by esoteric/molecular pathology tests and anatomic pathology. The future, however, holds significant promise for drug of abuse and anatomic pathology testing. The future growth in the US anatomic pathology (AP) segment is driven by strong growth in personalized laboratory testing on tumor tissues and other key factors. The report, in this context, offers effective information and analysis on the market landscape for key tests type with special emphasis on their future performance.
The US market for clinical laboratory diagnostics is highly fragmented with large number of labs offering services in different states of the country. Some players, however, have leading edge in comparison to other companies. Quest diagnostics, LabCorp and Sonic Healthcare are the key independent laboratories that have augmented their reach in the market with proper focus on consolidation activities. Our report entitled “US Clinical Laboratory Testing Market Assessment” provides an in-depth insight into the operations, services, M&A activities, financial performance and strengths and weaknesses of the key players in order to gauge their attractiveness in terms of investment and future participation in the market.
The report is an outcome of an in-depth research and prudent analysis of the US clinical laboratory testing market that emphasizes the reliability of data provided and presentation. It covers all the key aspects of market and investigates trends that are likely to impact the industry in the long run. Segment-wise analysis focuses upon the relevant information and key developments. Overall, the report is likely to be proved beneficial for all those entities who want to enter the market or make decisions regarding investment.